FDA Inspection
Tissue Transplant Technology, Ltd.Tissue Transplant Technology, Ltd. – FDA Inspection, May 25, 2012
Record Details
This FDA Inspection record concerns Tissue Transplant Technology, Ltd., with an inspection on May 25, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- May 25, 2012
- Product Type
- Biologics
View Company Profile
ID · 0f3a567b-aa7a-4a4c-b0f8-e6fc7ed3b7aa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 783591
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.180(a)Procedures to meet core CTGP
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Tissue Transplant Technology, Ltd.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 3, 2024 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 18, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 19, 2018 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 9, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 8, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Tissue Transplant Technology, Ltd.
- FDA Inspection 1230830 - 2024-05-03
- FDA Inspection 1162516 - 2022-02-18
- FDA Inspection 1048948 - 2018-04-19
- FDA Inspection 1027128 - 2017-08-09
- FDA Inspection 929262 - 2015-06-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.